Jun 4, 2026 04:15PM
Jun 4, 2026 04:15PM
May 21, 2026 09:30AM
May 21, 2026 09:30AM
May 7, 2026 04:01PM
Apr 29, 2026 08:30AM
Apr 29, 2026 08:30AM U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir
Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM
Apr 17, 2026 08:30AM
Apr 17, 2026 08:30AM
Apr 14, 2026 12:03PM
Apr 14, 2026 12:00PM
Apr 8, 2026 09:02AM TD Cowen on Gilead Sciences (GILD): 'We Are Excited By Gilead's Recent String Of Deals'
Apr 8, 2026 08:52AM
Apr 8, 2026 06:01AM
Apr 7, 2026 09:33AM
Apr 7, 2026 08:32AM
Apr 7, 2026 08:30AM
Apr 1, 2026 04:13PM
Apr 1, 2026 04:13PM Gilead Extends Tender Offer to Acquire Arcellx
Mar 31, 2026 06:19AM
Mar 24, 2026 03:02PM
Mar 24, 2026 06:36AM
Mar 24, 2026 05:23AM
Mar 23, 2026 06:30PM
Mar 23, 2026 06:15PM
Mar 23, 2026 06:15PM Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Feb 25, 2026 01:50PM
Feb 25, 2026 01:44PM
Feb 25, 2026 10:02AM
Feb 24, 2026 09:38AM
Feb 24, 2026 08:23AM
Feb 23, 2026 12:32PM
Feb 23, 2026 09:31AM Raymond James on Legend Biotech Corp. (LEGN): 'Arcellx Takeout Indicates Legend is Hugely Undervalued'
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM
Feb 17, 2026 08:30AM
Feb 10, 2026 04:01PM
Dec 24, 2025 07:00AM
Dec 22, 2025 08:02AM
Dec 22, 2025 08:00AM Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
Dec 15, 2025 08:30AM
Dec 15, 2025 08:30AM
Dec 12, 2025 10:31AM
Nov 18, 2025 05:09AM
Nov 18, 2025 05:00AM
Nov 13, 2025 08:30AM
Nov 13, 2025 08:30AM Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial
Oct 31, 2025 08:00AM

1,157,739 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All